Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 19, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Newly Diagnosed Glioblastoma

Interventions

DRUG

combinations of up to 3 FDA approved drugs from a panel of compounds

personalized drug combinations

Trial Locations (1)

RECRUITING

Swedish Medical Center, Seattle

All Listed Sponsors

lead

Swedish Medical Center

OTHER